Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 8/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.55 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3022704 | 1.00 | ADORA1 (0.55) | ADORA1ADORA3ADORA2ACYP2D6ADORA2B | |
| SCHEMBL3027373 | 0.87 | ADORA2A (0.57) | ADORA1ADORA3ADORA2AADORA2B | |
| SCHEMBL3024769 | 0.86 | ADORA2A (0.51) | ADORA1ADORA3ADORA2ACYP2D6ADORA2B | |
| SCHEMBL3129561 | 0.78 | ADORA3 (0.50) | ADORA1ADORA3ADORA2A | |
| SCHEMBL3023215 | 0.78 | ADORA3 (0.50) | ADORA1ADORA3ADORA2A | |
| SCHEMBL3022991 | 0.75 | ADORA2A (0.58) | ADORA1ADORA3ADORA2ACYP2D6ADORA2B | |
| SCHEMBL3022156 | 0.73 | ADORA2A (0.55) | ADORA1ADORA3ADORA2AADORA2B | |
| SCHEMBL5399226 | 0.73 | ADORA1 (0.72) | ADORA1ADORA3ADORA2ACYP2D6ADORA2B | |
| Gr-79236 SCHEMBL24436934 | 0.71 | ADORA3 (1.00) | ADORA1ADORA3ADORA2ACYP2D6ADORA2B | |
| Gr-79236 SCHEMBL24437080 | 0.71 | ADORA3 (1.00) | ADORA1ADORA3ADORA2ACYP2D6ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2205601-A1 | PURINE DERIVATIVES AS ADENOSINE AL RECEPTOR LIGANDS | Novartis Ag (CH) | 2010-07-14 | — | — | EP | claimed |
| WO-2009050199-A1 | PURINE DERIVATIVES AS ADENOSINE AL RECEPTOR LIGANDS | NOVARTIS AG (CH) | 2009-04-23 | — | — | WO | claimed |